Company & Sponsor Intelligence

University of Saskatchewan

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials3
Recruiting1
Completed2
Countries1

Therapeutic footprint

alzheimersmultiple_sclerosisstroke

Indexed studies

NCT03039400Physiotherapist-guided Home Exercise in Moderate to Severe MS
multiple_sclerosis · Canada
NA
NCT07178678Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease
alzheimers · Canada
PHASE2
NCT02948725Clinical Application of Cross-education During Stroke Rehabilitation
stroke · Canada
NA

Intelligence layer updated: 2026-11-04 06:12:09.749896+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →